Chiropractic Economics ® 2022

Dr. Kirk Gair,DC, IDE, has been in private practice since 1999 and began using Erchonia low-level lasers in 2004. During that time, he has worked with athletes of all levels, including Super Bowl Champions, MLB and national and state champions. Due to his laser protocols, he has patients come from all over the U.S. for help. Even though his is a 100% referral practice, he has a long waiting list due to his success.
 
Dr. Gair has also completed additional training in functional medicine and functional neurology under the guidance of internationally acclaimed Dr. Datis Kharrazian.

Dr. Kirk Gair,DC, IDE, has been in private practice since 1999 and began using Erchonia low-level lasers in 2004. During that time, he has worked with athletes of all levels, including Super Bowl Champions, MLB and national and state champions. Due to his laser protocols, he has patients come from all over the U.S. for help. Even though his is a 100% referral practice, he has a long waiting list due to his success.
 
Dr. Gair has also completed additional training in functional medicine and functional neurology under the guidance of internationally acclaimed Dr. Datis Kharrazian.

Post COVID-19 Office Success with the Zerona Z6 Laser  

Has your business been affected by the recent health pandemic? Are you interested in learning how you can take advantage of a rapidly growing market and create an additional cashflow stream for your business?   

In this webinar, you will learn about:

 How you can take advantage of a new revenue stream for your office

•  Statistics of spending on aesthetic treatments in difficult times

•  Zerona vs. competing devices - advantages of using touchless device

•  Successful office set up, consultations, and treatments

•  Real world solutions & success stories from your peers

•  Exceptional marketing support

•  Easy treatment payment options for your patients


About our speakers: Dr. Dan Muphy & Steven Shanks

Exploring the Application & Science of Low-Level Laser Therapy 

Watch Now

Register now to watch the recorded webinar

Watch the FREE Webinar Now

WEBINAR TOPICS:

Integrate concepts in laser photon therapy: wavelength, frequency, speed of light, fluence, penetration, secondary and primary physiological influences.

Contrast the differences between thermal and non-thermal laser therapy.
 
Develop the relationship between mitochondria, free radicals, ATP, cytochrome c oxidase enzyme, and laser photon therapy.
 
Discuss the physiology of applying laser therapy to both the anatomical part of injury/complaint and to the nerve roots that innervate that anatomical part.
 
Explain the biphasic nature of laser photon therapy as related to evolutionary biology and current clinical applications.

Daniel Murphy, DC, DABCO is a well-recognized, award winning chiropractor and a popular instructor who teaches internationally while maintaining a part-time clinical practice. He has taught over 1,610 twelve-hour postgraduate continuing education classes. He also serves as part-time undergraduate faculty professor at Life Chiropractic College West, where he is currently teaching classes to seniors in the management of spinal disorders. He has taught post-graduate classes for a long list of chiropractic colleges and individual programs. He is a contributing author to several books and a quarterly columnist in the American Journal of Clinical Chiropractic. From 2003 – 2009, Daniel Murphy, DC, DABCO served as the Vice President of the International Chiropractic Association. In 2014, he was awarded the Lifetime Achievement Award from the International Association of Functional Neurology and Rehabilitation (IAFNR).

Steven Shanks, the President of Erchonia Corporation; stands at the forefront of medical innovation and the growth of low level laser technology. He has spent the last 20 years advocating and promoting bio-modulation as an alternative modality to invasive procedures and primary treatment. A calculated risk taker, with profound understanding of clinical research, he has devoted his knowledge to researching applications that advance safe, effective and non-invasive medical technology. Even with the numerous FDA issued market clearances to his credit, all awarded based on FDA IRB approved Level 1 clinical trials and the creation of a new product code OLI, Steven Shanks continues to look for opportunities where low level laser as a medical modality can improve healthcare and the quality of life.